KRMD vs. ANIK, OSUR, NVRO, GUTS, CERS, TMCI, LUNG, SKIN, TCMD, and SGHT
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include Anika Therapeutics (ANIK), OraSure Technologies (OSUR), Nevro (NVRO), Fractyl Health (GUTS), Cerus (CERS), Treace Medical Concepts (TMCI), Pulmonx (LUNG), Beauty Health (SKIN), Tactile Systems Technology (TCMD), and Sight Sciences (SGHT). These companies are all part of the "surgical & medical instruments" industry.
Anika Therapeutics (NASDAQ:ANIK) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.
Anika Therapeutics currently has a consensus target price of $29.50, indicating a potential upside of 19.14%. KORU Medical Systems has a consensus target price of $3.50, indicating a potential upside of 65.09%. Given Anika Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than Anika Therapeutics.
In the previous week, Anika Therapeutics had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Anika Therapeutics and 2 mentions for KORU Medical Systems. Anika Therapeutics' average media sentiment score of 1.55 beat KORU Medical Systems' score of 0.94 indicating that KORU Medical Systems is being referred to more favorably in the news media.
KORU Medical Systems has a net margin of -45.24% compared to KORU Medical Systems' net margin of -45.39%. KORU Medical Systems' return on equity of 0.48% beat Anika Therapeutics' return on equity.
91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 5.9% of Anika Therapeutics shares are held by company insiders. Comparatively, 21.7% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
KORU Medical Systems has lower revenue, but higher earnings than Anika Therapeutics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks.
Anika Therapeutics received 264 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 64.38% of users gave Anika Therapeutics an outperform vote while only 60.00% of users gave KORU Medical Systems an outperform vote.
Anika Therapeutics has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.
Summary
Anika Therapeutics and KORU Medical Systems tied by winning 9 of the 18 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
